Dr. Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases, is cautiously optimistic about Moderna Inc’s (NASDAQ: MRNA) coronavirus vaccine candidate and told NPR that, …
Read More
Dr. Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases, is cautiously optimistic about Moderna Inc’s (NASDAQ: MRNA) coronavirus vaccine candidate and told NPR that, …
Read More